{"SPADE_N_06371": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_06371", "Peptide Name": "B1-Arg", "Source": "Cathelicidin-BF15 C-terminal amidated derivative B3", "Family": "", "Gene": "Not found", "Sequence": "VKRFKKFFRKLKKRV", "Sequence Length": 15, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:MCF-7 (IC50=5.5 µM); K562 (IC50=8.7 µM)", "Hemolytic Activity": "Not available", "Cytotoxicity": "GES-1:IC50=93.3 µM", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C97H166N30O16", "Mass": 2008.55, "PI": 12.0, "Net Charge": 9, "Hydrophobicity": -1.09, "Half Life": "Mammalian:100 hourYeast:>20 hourE.coli:>10 hour", "Literature": [{"Title": "Design, synthesis and biological evaluation of novel peptides with anti-cancer and drug resistance-reversing activities", "Pubmed ID": "25462264", "Reference": "Eur J Med Chem. 2015 Jan 7;89540-8.", "Author": "Deng X, Qiu Q, Yang B, Wang X, Huang W, Qian H.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=25462264"}], "Frequent Amino Acids": "KFR", "Absent Amino Acids": "ACDEGHIMNOPQSTUWY", "Basic Residues": 9, "Acidic Residues": 0, "Hydrophobic Residues": 6, "Polar Residues": 11, "Positive Residues": 9, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_26361", "Similarity": 1.0, "Sequence": "VKRFKKFFRKLKKRV"}, {"SPADE_ID": "SPADE_UN_22042", "Similarity": 1.0, "Sequence": "KRFKK"}, {"SPADE_ID": "SPADE_N_06362", "Similarity": 0.9333333333333333, "Sequence": "VKRFKKFFRKLKKAV"}]}}}